Cargando…
Metformin, Macrophage Dysfunction and Atherosclerosis
Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to treat many diseases. More and more evidence shows that metformin can regulate the function of macrophages in atherosclerosis, including reducing the differentiation of monocytes and inhibiting the inflammation...
Autores principales: | Feng, Xiaojun, Chen, Wenxu, Ni, Xiayun, Little, Peter J., Xu, Suowen, Tang, Liqin, Weng, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215340/ https://www.ncbi.nlm.nih.gov/pubmed/34163481 http://dx.doi.org/10.3389/fimmu.2021.682853 |
Ejemplares similares
-
Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function
por: Deng, Mingying, et al.
Publicado: (2020) -
Vascular homeostasis in atherosclerosis: A holistic overview
por: Xu, Suowen, et al.
Publicado: (2022) -
Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis
por: Jiang, Hui, et al.
Publicado: (2022) -
Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function
por: Ding, Yu, et al.
Publicado: (2021) -
Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling Pathway
por: Xu, Suowen, et al.
Publicado: (2022)